SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-053833
Filing Date
2020-10-05
Accepted
2020-10-05 17:56:51
Documents
2
Period of Report
2020-10-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1633
2 POA DOCUMENT poa.txt EX-24.3_940476 3583
  Complete submission text file 0001209191-20-053833.txt   6648
Mailing Address 1111 DR. FREDERIK-PHILIPS BLVD SUITE 420 MONTREAL A8 H4M 2X6
Business Address 1111 DR. FREDERIK-PHILIPS BLVD SUITE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Issuer) CIK: 0001408443 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address DURATA THERAPEUTICS, INC. 200 SOUTH WACKER DRIVE SUITE 2550 CHICAGO IL 60606
Business Address
Giles Lisa M. (Reporting) CIK: 0001568850 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38899 | Film No.: 201224808